Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Patients on a stable dose of ACE inhibitor or ARB medication who are scheduled for elective surgery will be randomized to take their ACE inhibitor or ARB up to and including the morning of surgery, or to hold them a day prior to the surgery. The patients will be followed for 30 days after surgery to assess any adverse health outcomes.
Epistemonikos ID: a78cfbd581bfad6d2475c0f676669b7d0301cb6f
First added on: May 05, 2024